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Abstract
Background: Tuberculosis (TB) control programmes rely heavily on laboratories to support both clinical care and
public health. Qualified personnel with adequate technical and managerial skills comprise an integral component of
any quality assured laboratory. Training a new generation of TB laboratory specialists was identified as a critical
priority in the European Union /European Economic Area (EU/EEA). A tailored training programme for TB reference
laboratory professionals was developed and implemented within the European Reference Laboratory Network for
Tuberculosis to increase the pool of technical experts available to step into leadership roles in the TB laboratory
community. Three cohorts of selected laboratory specialists participated in a series of trainings from 2009 to 2016.
Methods: We conducted an evaluation of the training programme using a structured questionnaire administered
via the EUSurvey website, with the aim of documenting the benefits and contribution as well as suggesting
improvements and future direction of the programme. All graduated participants and all current ERLTB-Net
members were invited to participate in the online survey and descriptive quantitative analysis was performed.
Results: The evaluation found significant benefits for both the participants and the participants’ institutions, with
improvements being reported in laboratory practices and management including implementation of new
diagnostic techniques and career progression for participants. The training programme differed from other
international and European initiatives in a number of important ways; the curriculum is unique in the scope and
range of topics covered; the programme targets senior level professionals and future directors; cohorts were limited
to 8–10 participants; and the programme involved a number of workshops (5–7) taking place over a two-year
period. Relationships and collaborations established between individuals and institutions were valued as an
important success of the initiative. Suggestions on how the impact of the programme could be enhanced included
equipping participants to perform laboratory assessments in low-resource settings outside the EU, thus bolstering
global TB control.
Conclusion: Based on the findings presented the training programme has proved to be successful in developing
leadership, expertise, partnerships and networks to support TB laboratories and has contributed significant benefits
to strengthening European National Reference laboratories in the fight against TB.
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Background
Tuberculosis (TB) causes the highest number of deaths
due to an infectious disease in the world, is the leading
killer of people living with HIV and is associated with
major challenges related to antimicrobial resistance [1].
In 2019, an estimated 10 million people developed TB
and 1.5 million died from the disease worldwide, includ-
ing 251,000 deaths among persons living with HIV [2].
Multidrug-resistant TB (MDR-TB) caused by bacilli re-
sistant to at least two key antimicrobials (rifampicin and
isoniazid) remains an emerging public health challenge
globally [3, 4]. Accurate results from TB diagnostics and
drug susceptibility tests enable TB programmes to iden-
tify TB cases and select appropriate treatment. There-
fore, laboratories play a critical role in TB control both
in supporting clinical care and public health activities:
detecting active TB cases, monitoring treatment, con-
tributing to outbreak investigations, contact tracing and
surveillance activities [5–9].
Laboratories are complex systems comprising many
components including infrastructure, equipment and
technologies. Vital to their operation are the human re-
sources and the systems that manage the processes and
implement the standards to produce reliable, accurate
and actionable results [10]. In addition, successful imple-
mentation of new and innovative diagnostic tests and
technologies requires functional networks of laboratories
with trained and motivated staff, robust quality manage-
ment systems (QMS) and safe working environments.
To achieve and maintain resilient laboratory systems,
special consideration needs to be given to training pro-
grammes for laboratory management and leadership,
strengthening laboratory networks through partnerships
and pooling of resources, and developing strategies to
integrate laboratories’ functions [10]. Qualified
personnel with relevant technical and managerial skills
comprise an integral component of a quality assured la-
boratory and are essential for obtaining and retaining la-
boratory accreditation [11]. A lack of personnel with
advanced technical skills has been reported in many set-
tings as a major obstacle to performing complex labora-
tory tests [5].
Existing TB laboratory training initiatives at the Global
and European level have predominantly focussed on
technical issues, QMS, planning and accreditation. The
Stop TB Partnership’s Global Laboratory Initiative (GLI)
[12, 13] developed a training package for TB diagnostic
network planning which is predominantly administered
through an online portal. This does not provide dedi-
cated in-person practical training, which is vital for de-
velopment of leadership and management skills, as well
as for gaining expertise in conducting assessment visits.
Another training offered by the European TB Laboratory
Initiative (ELI) offers regional workshops that bring
together laboratory specialists from countries with high
TB and MDR-TB rates to strengthen their technical cap-
acity in TB and MDR-TB diagnosis and implementing
biosafety measures [14]. While these initiatives support
the implementation of the World Health Organization
(WHO) End-TB strategy [15] they do not specifically
target the needs of senior level staff and laboratory man-
agers serving as TB laboratory specialists in the EU/EEA.
Thus, training of a new cadre of mycobacterial labora-
tory specialists was identified as an urgent requirement
in the EU TB laboratory network [5, 16].
In order to strengthen the development of medium
and senior level professionals, an innovative training
programme was developed and implemented within the
European Reference Laboratory Network for Tubercu-
losis (ERLTB-Net; ERLN-TB [before 2014]) from 2009
onwards [17]. The ERLTB-Net training programme
aimed to increase the pool of technical experts with ad-
vanced knowledge of TB diagnostic methods, available
to take leadership roles in national TB laboratories, and
to support national TB laboratory systems and the EU/
EEA TB diagnostic community. The curriculum for the
training programme was developed by a group of TB ex-
perts experienced in providing advanced level training
based on needs identified through External Quality As-
sessment (EQA) rounds [11] and decisions made at
ERLTB-Net annual meetings. Between 2009 and 2016,
the programme was provided to 22 laboratory specialists
divided into three cohorts. All participants were sub-
jected to a rigorous selection process. Trainees were first
nominated by ERLTB-Net laboratories who selected
them based on specific criteria including their work ex-
perience, level of seniority in their current position as
well as potential benefits for the supporting laboratory.
As potential candidates they then had to submit a port-
folio including a CV and motivation letter highlighting
their relevant experience and suitability as a trainee. Fol-
lowing shortlisting by the ERLTB-Net senior selection
panel, participants were interviewed to confirm suitabil-
ity before being enrolled as trainees.
The programme was delivered through a series of
small (three to five per training cycle) and large work-
shops (two per training cycle) lasting 3 days each, with
each training cycle spanning 2 years (see Additional file
1 for details of the topics covered). Small trainings were
held at two ERLTB-Net member supranational TB refer-
ence laboratories fully accredited to ISO15189 standards
located in the UK and Italy. These were predominantly
laboratory-based and included both demonstration,
interactive lectures and hands-on components covering
basics in TB laboratory diagnosis, molecular diagnostic
methods, latent TB diagnosis, TB epidemiology and con-
tact tracing, laboratory assessment and TB laboratory
design. Large trainings were combined with annual
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ERLTB-Net meetings and provided opportunities for de-
veloping networks, leadership, management and training
skills through direct involvement of trainees in the meet-
ing organization, teaching and discussions. Topics for
large trainings included laboratory operations, TB pol-
icies and guidelines, laboratory financial management as
well as emerging technologies in TB laboratory diagno-
sis. After completing the programme, graduates were in-
volved in a variety of activities including workshops,
taskforce visits, staff exchange visits and laboratory as-
sessment visits.
All trainings were delivered by recognised experts in
TB laboratory management, laboratory diagnostics, epi-
demiology and public health comprising of ERLTB-Net
Laboratory Directors, senior staff members and external
speakers from WHO, national public health bodies, and
leading Universities. Following participant feedback from
trainees of cohort one and two some modules and con-
tent were deemed less relevant or redundant for the tar-
get audience while other topics were incorporated into
remaining modules so the course content was modified
slightly. This demonstrated that participant feedback
was incorporated at an early stage to improve the course
and make it more relevant and impactful, otherwise
training for all cohorts followed the same training cur-
riculum developed as a part of ERLTB-net activities.
The goal of this study was to evaluate the training
programme by exploring the benefits experienced by the
participants and their supporting institutions throughout
the period 2009–2016. We aimed to document the im-
pact of the training on participants’ career development
and the value of the training to the participants’ institu-
tions. In addition, we sought to identify gaps and limita-
tions of the training programme and make
recommendations for improvement, development and its
future direction.
Methods
Study design and setting
Two structured web-based questionnaires (see Add-
itional files 2 and 3) were developed and distributed
using an online platform. The first questionnaire was de-
signed for participants who had completed the
programme and consisted of 34 questions designed to
evaluate their individual experience with the training.
The questionnaire included questions on the application
process, the quality of the training programme, partici-
pation in visits to other countries and perceived personal
benefits. The second questionnaire was sent to heads of
all ERLTB-Net member laboratories and consisted of 13
questions aimed at assessing the benefits of the
programme from the perspective of the network mem-
bers. An additional questionnaire (see Additional file 4)
was circulated to all persons who participated in the
training programme following initial analysis to augment
information on the benefits of the training and the types
of missions trainees had participated in.
Applying the methodology developed by Kilpatrick
et al. to assess the perceived benefits of the training for
the participants we compared initial expectations upon
acceptance to the training programme to the level to
which these expectations were met [18]. From a choice
of 13 pre-defined answers (see Additional file 2), partici-
pants were asked to choose the four most relevant. Ini-
tial expectations were compared with the perceived
principle gains or major self-reported achievements, to
assess if the training programme allowed them to
achieve additional skills versus original expectations. Ob-
jective benefits were assessed using a set of questions ad-
dressing individual’s career progression, process or
system improvements, and new methodologies imple-
mented in their home institutions.
Participants
All individuals who had completed the programme be-
tween the years 2019–2016 (N = 22–1 deceased = 21)
were invited to take part in the evaluation of the
ERLTB-Net training programme along with all current
ERLTB-Net members represented by heads of laborator-
ies (N = 31).
Data collection and analysis
The survey questions were uploaded to the EUSurvey
(https://ec.europa.eu/eusurvey/) website, a web-based
tool, in order to allow easy distribution, access and re-
sponses submission for all respondents with the option
to remain anonymous. Upon completion of data collec-
tion, which lasted two months, the responses were
exported to Microsoft Excel (Microsoft Corporation,
Redmond, Washington) spreadsheets for compilation of
the data sets followed by descriptive quantitative
analysis.
Results
Characteristics of the respondents
Response rates to the questionnaires were 85.7% (18/21
training participants) and 58.0% (18/31 heads of TB la-
boratories). Of the 18 respondents to the participant
questionnaire, five had been trained in cohort 1, seven in
cohort 2 and six in cohort 3. The highest level of educa-
tion at the time of application to the training was Bach-
elor of Science degree (BSc) 17%, Master of Science
(MSc) 33%, and Doctor of Philosophy (PhD) 50%.
Seventy-two percent of the respondents were > 35 years
old, 17% within the age range 31–35 years and 11% in
the range 25–30 years old. The level of seniority at the
time of application, judged as an individuals’ position
within their organisation, ranged between intermediate
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(39%) and senior level (61%). Of the 18 participants, 15
(84%) were employed at a National Reference Laboratory
(NRL) at the time of application while 2 (11%) were
working at a Supra- National Reference Laboratory
(SNRL) and one respondent worked at a clinical labora-
tory. The majority of applicants had some knowledge
about the training programme prior to application, with
88% reporting that the institution in which they worked
was a member of the network, and/or they had col-
leagues who had already participated in the training
programme. All applicants reported that they were ad-
equately supported by their home institution throughout
the application process.
Subjective benefits
The key expectations of the training programme in-
cluded receiving scientific training, development of pro-
fessional relationships and building managerial expertise
(n = 13 respondents). The self-reported achievements of
the training participants were generally in agreement
with their expectations, with scientific training, develop-
ment of professional relationships, managerial expertise,
networking skills and participation in conferences being
the achievements reported by most participants (Fig. 1).
In all but one category (dedicated practical training),
the principle gains reported surpassed the participants’
initial expectations. In addition to what was expected
from the training programme, participants learned to
work in teams (18 respondents), to share expertise (17
respondents) and received scientific training in TB diag-
nostic and research methodologies (17 respondents). Al-
though categories “get more publications”; “get some
editorial experience”; and “get a higher position” had not
been selected as initial expectations by any participant,
these were self-reported as achievements by five, five,
and three participants, respectively.
ERLTB-Net members (N = 18) that had nominated
staff to participate in the programme gave similar re-
sponses to those of the training participants regarding
initial expectations (Fig. 2). The majority of the network
members cited the following six reasons for supporting
the application of their staff member: to get new experi-
ence, to get a scientific training, to get a dedicated prac-
tical training, to develop new professional relationships,
to contribute to team work and sharing knowledge with
new colleagues and peers and to learn new perspectives
on management and organization of TB reference la-
boratories and national laboratory networks.
Benefits for training participants
All respondents reported that the ERLTB-Net training
empowered them to improve the diagnostic services in
their institution, expanded their expertise in advanced
TB diagnostics, and facilitated their career progression.
Of the 18 respondents, nine (50%) had progressed to a
more senior position since completion of the training
programme; seven had been promoted to a more senior
position in the same institution, one had moved to a
more senior position in a different public health institu-
tion in the same country and one had obtained a more
senior position in an international public health organ-
isation. Nearly three quarters (72%) of respondents re-
ported that they had established links with other
institutions and initiated information sharing, expertise
sharing and/or new projects through collaborations
made during the training programme.
Following graduation, new methods, policies and prac-
tices had been introduced in all laboratories with many
Fig. 1 Comparison of initial expectations with principle gains of training participants expressed in % of respondents
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laboratories implementing more than one change (Fig. 3).
Changes ranged from improvements in methodologies,
implementation of additional techniques such as liquid
culture, liquid culture for drug-susceptibility testing
(DST), molecular identification, molecular DST,
interferon-gamma release assay (IGRA), epidemiological
genotyping, next generation sequencing (NGS) and im-
provements to the QMS, biosafety, training and diagnos-
tic algorithms, guidelines and policies.
Laboratory directors were asked to grade (1–10) the
perceived gains for their institution of having a staff
member participating in the training programme. Areas
which respondents graded > 5 included: team work and
sharing knowledge with new colleagues and peers, im-
plementation of new practices, increased international
visibility, participation in joint projects with other insti-
tution, new perspectives on TB laboratory organization
and activity, implementing new methods/protocols and
guidelines/policies and becoming members of national/
international organizations. Building partnerships and
collaborations between participating laboratories was
considered a key benefit of the training and one which
warranted further investment.
“In my opinion there must be more focus on the
twinning programmes between countries. Also, rela-
tionships already established between labs should be
further supported.” (ERLTB-Net member).
Participation in missions
Ten of the 18 graduated training participants reported
having taken part in one or more country and/or labora-
tory assessment missions. All of these were conducted at
NRL’s with the duration of missions varying from 1 to 3
days. The types of missions ranged from joint ECDC/
WHO-Europe missions, ERLTB-Net commissioned task
Fig. 2 Expectations of European Reference Laboratory for TB Network members expressed in % of respondents
Fig. 3 Improvements implemented by training participants (N = 18) in home institutions following completion of the training programme
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force visits and exchanges, missions to regional labora-
tories and international WHO commissioned missions
to laboratories in Africa. Participating in missions was
seen by support experts as a key way for trainees to
apply their knowledge in a tangible way. This was also
highlighted as an important learning opportunity for
those coming from more advanced laboratories on the
diverse contextual challenges and resource limitations
experienced in different countries across the region.
“If funding would be available, it would be great to
make. .. a mission available for each support expert
during training... . you really grow as a person after
such mission. At the same time you’ll be very hum-
ble by seeing the difference in possibilities of various
labs, due to aspects like economy, biosafety, burden
of MDR-TB patients and so on.” (newly trained
Support Expert).
Of the 18 heads of TB laboratories participating in the
network survey, five had hosted a mission by a training
participant. Outputs received following the mission in-
cluded post-visit debriefing, written reports, lists of rec-
ommendations and support provided on implementation
of recommendations. A high proportion (80%) of labora-
tories who had hosted a mission reported making
changes or taking action based on the findings of the
mission. Members reinforced the point that newly
trained support experts should be afforded the oppor-
tunity to participate in missions and that the training
should be continued for additional cohorts.
Satisfaction levels and suggested improvements
The majority of respondents (91.0–100% for different
training events) felt that the training content was rele-
vant and within the scope of the training program with
overall satisfaction levels reaching 75.0–100% of partici-
pants. Suggestions on how the training programme
could be improved or optimised included making the
programme longer and expanding it to cover additional
topics including new technologies, addressing emerging
problems like migration and its implications for TB
diagnostic services, development of networking capabil-
ities and expanding research and education opportun-
ities (see Additional file 5).
“Should look at how research collaborations can be
built between countries and encourage SNRL’s to
support further education of colleagues at NRL’s”
(newly trained Support Expert).
Sixty-eight percent of the ERLTB-Net members were
satisfied with the programme and recommended
changes included: utilising existing collaborations and
twin arrangements between the laboratories, concentrat-
ing on developing practical skills, support for research
collaborations and implementation of online training
(see Additional file 6). Some support experts suggested
advocating for the training programme to be recognised
by WHO so that support experts within the network
could be called on as additional expertise to bolster Glo-
bal TB efforts.
“Training should allow support experts to perform
assessments with WHO outside the European con-
text in the developing world where the need is
greatest” (newly trained Support Expert).
An important recommendation which was highlighted
by a number of training participants was that newly
trained support experts should be involved more in lead-
ership and management of the network activities and
that opportunities to participate in the ERLTB-Net an-
nual meetings should be expanded.
“I think younger experts should be encouraged to
participate more in the activities of the management
team decision and policy discussions and to broaden
the core group beyond the more senior experts”
(newly trained Support Expert).
Discussion
Resilient laboratory systems are critical to support TB
programmes, infectious disease diagnostics and public
health systems. Global Health crises such as the current
Coronavirus disease 2019 (COVID-19) Pandemic and
the 2014–16 West Africa Ebola outbreak highlight the
importance of functional laboratory systems and diag-
nostic capabilities [19–22]. Unfortunately, laboratory
systems and infrastructure have long been neglected and
under-resourced in many settings. Investment in training
and upskilling of human resources should be considered
a critical component of laboratory system strengthening.
Recognising this need in the EU Region, the ERLTB-Net
set out a clear objective to invest in developing a cadre
of future leaders within the TB diagnostic community.
A tailored training programme for TB reference la-
boratory experts was developed and implemented within
ERLTB-Net to address the specific needs of the EU/EEA
Member States [17]. The ultimate goal of the training
programme was to increase the pool of technical experts
available to step into leadership roles in national TB la-
boratories and in the EU/EEA international TB diagnos-
tic community. The course specifically targeted future
leaders in TB diagnostics in the European region, there-
fore recruited those likely to take up management and
leadership positions in TB laboratories within the EU, to
achieve optimal impact. A total of 21 persons were
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trained within this programme in 2009–2016 and many
of them subsequently took up leadership roles in TB la-
boratories. A high proportion of training participants re-
ported having been promoted to more senior positions
nationally and internationally following their graduation,
indicating that the training program was beneficial for
their career progression and fulfilling one of the funda-
mental objectives of the training programme. Satisfac-
tion with the training programme was generally high
and self-reported achievements exceeded initial expecta-
tions in the vast majority of categories, indicating signifi-
cant perceived benefits for the trainees. Practical
training was the only area where expectations were high
but gains were relatively low (Fig. 1) which could be ex-
plained by the fact that the advanced training covered
various aspects of which hands on training was just one
component. Inclusion of multiple components spanning
theory and practice, combined with leadership and man-
agement aspects, allowed trainees to gain a broader ex-
pertise which is demonstrated by significant gains in
other areas.
The course was offered to TB NRL’s in the entire
European region where the vast disparity in public
health development, available resources and TB diagnos-
tic capabilities is evident between laboratories in these
countries. One of the significant objectives and benefits
of the ERLTB-Network is to act as a platform to coord-
inate capacity building of developing NRL’s by other
high-resource reference laboratories. Our findings dem-
onstrate the critical opportunities available for more ad-
vanced NRL’s and SNRL’s in the European region to
share their experiences and support development of
those operating in low-resource contexts through mis-
sions and collaborations. Furthermore, an important ob-
jective of this training programme was to harmonize
diagnostic methodologies across the European region.
Various new methods, policies and practices have been
implemented in participants’ home institutions following
graduation, achieving a key goal of the programme. Re-
cently Mathys et al. [23], demonstrated the value of net-
working activities in sharing expertise and developing
methodologies that could be used to improve quality
and laboratory performance within the ERLTB-Net and
beyond. Reported benefits for the ERLTB-Net further
supported these findings indicating that the programme
had a positive influence on the TB Laboratory network
at ground level.
It is widely accepted that to help ensure that laborator-
ies can effectively play their critical role in the detection,
prevention and control of diseases, laboratory directors
and senior laboratory managers require specialised train-
ing in leadership and management. To achieve this, in
2020, WHO expect to launch a new training programme
the Global Laboratory Leadership Programme (GLLP)
which is anticipated to greatly contribute to the labora-
tory profession globally. However, the content and
teaching modalities are still under development and it is
unclear if the programme will be administered in person
or through distance learning [24]. While there are cur-
rently a number of other training initiatives available to
support capacity building of laboratory staff, the ERLTB-
Net training programme which has been running for
more than a decade, differs from those available in a
number of important ways [13, 14]. Firstly, the training
curriculum is unique in the scope and range of topics
covered within the programme which includes education
on TB policy and guidelines; management, leadership
and organisation of TB laboratories; technical training
on new methodologies, as well as QMS and biosafety is-
sues. Secondly, the programme is pitched at a very high
level, targeting future directors and senior level profes-
sionals in TB diagnostics in the European region, which
has been identified as a critical need in the EU/EEA area.
The requirement for training of senior TB experts was
further supported by the results of a recent survey
(ERLTB-Net, unpublished data) demonstrating that
32.0% and 61.3% of senior technicians and heads of na-
tional TB reference laboratories in EU/EEA countries
are approaching retirement age (50 years +) or are above
retirement age. In countries that joined the EU in 2004
and later these proportions are even higher (42.1% and
63.6%, respectively). The recruitment process for this
training involved careful selection of participants based
on their long-term commitments, qualifications and
nominations from host institutions, prioritising labora-
tory experts already working in NRLs and SNRLs.
Thirdly, training cohorts are purposely limited in num-
ber with only eight to ten participants per cohort facili-
tating targeted training, fostering relationships and
encouraging collaborations to be built over the period of
the training. Finally, the programme took place at a
number of venues within the EU (UK and Italy), with
trainees participating in a number of small and large
workshops spread over the two-year period. This longi-
tudinal nature of training (as opposed to one off training
offered by many initiatives) further facilitated network
and relationship building, resulting in collaborations and
partnerships developing, with many subsequent positive
outcomes.
A high proportion (80%) of laboratories who had
hosted a visit by a support expert reported making
changes or taking action based on the findings of the
visit, demonstrating the usefulness of the exercise. The
findings clearly showed that support experts were enthu-
siastic to contribute to and participate in missions. Par-
ticipating in missions was seen by support experts as a
key way for trainees to galvanize and apply their learn-
ing, and to contribute to capacity building and
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harmonization of systems and practices across the Euro-
pean region. An important suggestion on how the im-
pact of the programme could be enhanced was that
graduated experts should also be trained in performing
assessments beyond the European context in low-
resource settings where the need is greatest, enabling
the training programme to support global TB control.
All of the respondents reported that they would rec-
ommend colleagues to apply for the training programme
and made a number of important suggestions on how
the programme could be improved which are being ex-
plored by the training coordinators for future cohorts. A
notable suggestion was that the programme should be
used to promote research collaborations between coun-
tries and encourage SNRLs to support further education
of colleagues at NRLs which would ultimately benefit
the ERLTB-Net. An additional suggestion included en-
suring that trained experts are continually involved in
the work of the Network and in future training and
meetings. Evidence that this is already being imple-
mented was visible at recent annual meetings where a
number of graduated experts contributed in both organ-
isational and teaching components. Suggestions for fu-
ture provision of online training courses, additional
practical training and further supporting relationships
and collaborations are also being explored.
Limitations
A number of limitations exist relating to the method-
ology of this study, including that the responses and
therefore results and conclusions are based on self-
reported participants’ opinion. Evaluations in the form
of pre- and post- tests were not performed and results
of post-training evaluations were not included in the
analysis presented here. Additionally, the information
about expectations was collected retrospectively and not
before the start of the training programme. We also
highlight the low response rate to the ERLTB-Network
questionnaire (58%). In addition, we did not gather in-
formation on other training courses attended by the
trainees which could have contributed to or augmented
the benefits and career progression of trainees which we
report here.
Conclusions
Based on the finding presented and discussed above we
believe that the concept of the ERLTB-Net training
programme has proved to be successful in developing
expertise, partnerships and networks to support TB la-
boratories in the EU/EEA and has contributed signifi-
cant benefits to European NRLs in the fight against TB.
This manuscript describes an important initiative with
demonstrated successes of career progression, improve-
ments in technical skills and competencies, development
of collaborations and value added to the broader TB
community. We propose that the training programme
described here would be extremely beneficial if imple-
mented within other regions outside the EU, for example
in Africa and Asia, where TB prevalence is high and la-
boratory systems are weak and traditionally neglected.
Now more than ever, public health programmes would
benefit from dedicated experts trained to lead and man-
age TB and infectious disease laboratories and this
manuscript describes a potential framework for
implementation.
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